Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/10495/21292
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Condino Neto, Antonio | - |
dc.contributor.author | Costa Carvalho, B. T. | - |
dc.contributor.author | Grumach, A. S. | - |
dc.contributor.author | King, A. | - |
dc.contributor.author | Bezrodnik, L. | - |
dc.contributor.author | Oleastro, M. | - |
dc.contributor.author | Leiva, L. | - |
dc.contributor.author | Porras, O. | - |
dc.contributor.author | Espinosa Rosales, F. J. | - |
dc.contributor.author | Franco Restrepo, José Luis | - |
dc.contributor.author | Sorensen, R. U. | - |
dc.date.accessioned | 2021-07-29T19:46:21Z | - |
dc.date.available | 2021-07-29T19:46:21Z | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 0301-0546 | - |
dc.identifier.uri | http://hdl.handle.net/10495/21292 | - |
dc.description.abstract | ABSTRACT: Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In this article, the authors review the current indications and therapeutic protocols in the Latin American environment. Immunoglobulin replacement therapy has been a safe procedure that induces dramatic positive changes in the clinical outcome of patients who carry antibody defects. | spa |
dc.format.extent | 16 | spa |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | eng | spa |
dc.publisher | Sociedad Española de Inmunología Clínica y Alergología Pediátrica | spa |
dc.publisher | Elsevier | spa |
dc.type.hasversion | info:eu-repo/semantics/publishedVersion | spa |
dc.rights | info:eu-repo/semantics/openAccess | spa |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/2.5/co/ | * |
dc.title | Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America | spa |
dc.type | info:eu-repo/semantics/article | spa |
dc.publisher.group | Inmunodeficiencias Primarias | spa |
dc.identifier.doi | 10.1016/j.aller.2012.09.006 | - |
oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
dc.rights.accessrights | http://purl.org/coar/access_right/c_abf2 | spa |
dc.identifier.eissn | 1578-1267 | - |
oaire.citationtitle | Allergologia et Immunopathologia | spa |
oaire.citationstartpage | 245 | spa |
oaire.citationendpage | 260 | spa |
oaire.citationvolume | 42 | spa |
oaire.citationissue | 3 | spa |
dc.rights.creativecommons | https://creativecommons.org/licenses/by-nc-nd/4.0/ | spa |
dc.publisher.place | Murcia, España | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_2df8fbb1 | spa |
dc.type.redcol | https://purl.org/redcol/resource_type/ART | spa |
dc.type.local | Artículo de investigación | spa |
dc.subject.decs | Inmunoglobulinas | - |
dc.subject.decs | Immunoglobulins | - |
dc.subject.decs | Enfermedades de Inmunodeficiencia Primaria | - |
dc.subject.decs | Primary Immunodeficiency Diseases | - |
dc.subject.decs | América Latina | - |
dc.subject.decs | Latin America | - |
dc.subject.proposal | Immunoglobulin replacement therapy | spa |
dc.subject.proposal | Subcutaneous immunoglobulin | spa |
dc.description.researchgroupid | COL0012426 | spa |
dc.relation.ispartofjournalabbrev | Allergol. immunopatol. | spa |
Aparece en las colecciones: | Artículos de Revista en Ciencias Médicas |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
CondinoAntonio_2012_GuidelinesHumanImmunoglobulin.pdf | Artículo de investigación | 1.25 MB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons